EE176 Cost-Utility Analysis of Fentanyl Sublingual Formulation in the Treatment of Breakthrough Pain in Adults With Cancer, Already on Opioid Maintenance Therapy for Chronic Cancer Pain in Italy
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.426
https://www.valueinhealthjournal.com/article/S1098-3015(22)02630-4/fulltext
Title :
EE176 Cost-Utility Analysis of Fentanyl Sublingual Formulation in the Treatment of Breakthrough Pain in Adults With Cancer, Already on Opioid Maintenance Therapy for Chronic Cancer Pain in Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02630-4&doi=10.1016/j.jval.2022.09.426
First page :
Section Title :
Open access? :
No
Section Order :
12232